Status:
NOT_YET_RECRUITING
Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Clinique des Cèdres, Echirolles
Conditions:
Spondylarthritis
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The QUESAM study aims to translate into French and validate the traduction of 2 screening questionnaires for spondylo-arthritis among people with inflammatory bowel disease. DETAIL (DETection of Arth...
Detailed Description
This is not an actual interventionnal or observationnal study. Investigators will try to provide a statistical validation of 2 questionnaires on people followed in gastro-enterology for an inflammator...
Eligibility Criteria
Inclusion
- Patient with an inflammatory bowel disease according to gastroenterologist
Exclusion
- No exclusion criteria
- Difficulty for understanding or reading french
- Persons covered by articles L1121-5 to L1121-8 of the French Public Health Code
- Patients with no social security coverage.
- Patients refusing to participate voluntarily.
Key Trial Info
Start Date :
May 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06998316
Start Date
May 1 2025
End Date
July 1 2026
Last Update
May 31 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Grenoble
Grenoble, France